Effects of maternal inhalation of 40% oxygen on fetal oxygen saturation by Berg, P.P. van den & Jongsma, H.W.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/21924
 
 
 
Please be advised that this information was generated on 2018-07-07 and may be subject to
change.
Volume 172, Number 0 
Am J Obstet Gynecol
Letters 1939
ter trophoblast cultures. We do not agree with this 
criticism. As cited in our study, our results showing 
increased invasiveness of first-trimester trophoblasts in 
vitro corroborate previous in vivo findings. We do, 
however, agree that we have not fully characterized the 
different subtype of trophoblasts in our cell population 
and thus cannot comment on the percentage of the 
various subtypes. Nevertheless, we do not accept Fein- 
berg’s assumption that only undifferentiated villous 
trophoblasts account for the invasive ability of cy to tro­
phoblasts throughout pregnancy, It can be argued that 
large numbers of extravillous or differentiated t:y to tro­
phoblasts indicate increased invasive capacity. In our 
study we tried to explain why first-trimester tropho­
blasts are more invasive than third-trimester tropho­
blasts in vivo and in vitro. We showed that third- 
trimester cy to trophoblasts retain invasive abilities that 
are important for placental physiologic mechanisms 
throughout pregnancy, The use of cy to trophoblasts in 
vitro as model for implantation is far from being ideal; 
it is the only model available for human studies. Thus in 
this context the applicability of first- and third-trimester 
trophoblasts for this purpose seems to be appropriate 
but remain an open issue.
Shlomo Slmnonovitz, MD, and S. Yagel, MD
Department o f  Obstetrics and Gynecology, Hadassah University, Mount 
Scopus, Jerusalem, 91240, Israel
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Pregnancy in an anephric woman
To the Editors: A 42-year-old woman underwent bilateral 
nephrectomy and cystectomy after 12 years of recidi- 
vant urotelial tumors in both kidneys, ureters, and 
urinary bladder. She was put on periodic hemodialysis 
treatment and after a period of training was installed at 
home in April 1993. Since the beginning she was 
started on recombinant human erythropoietin and 
reached 10 gm/dl with low doses in spite of ancphria 
(stable schedule 33 U/kg/wk). She had two children, 18 
and 16 years old, and very irregular menses, with 
amenorrhea since January 1994. In October she was 
seen for abdominal discomfort: and severe anemia with­
out ferropenia (hemoglobin 5.9 gm/dl, hematocrit 18%, 
ferritin 705 ng/ml, saturation 26%); ultrasonography 
disclosed pregnancy of estimated 17-week duration. At 
that time the dialysis regimen was 3.5 hours three times 
weekly. Her medications included calcium carbonate, 
vitamins, and erythropoietin 2000 U subcutaneously 
each week. This was increased to 4000 U subcutane­
ously three times weekly to maintain a hematocrit 
>28% (sixfold dose increase). Her home hemodialysis 
schedule was increased to 3 hours four times weekly at 
19 weeks’ gestation and five times weekly at 23 weeks’ 
gestation, with very good control of her urea and 
creatinine (mean predialysis urea 100 mg/cll and creat­
inine 5.5 mg/dl). Initially, blood pressure was controlled 
with fluid removal, but since the twentieth week predi­
alysis blood pressure was 150 to 160/90 to 95 and 
extended-release nifedipine (60 mg/clay) was added.
Consecutive ultrasonographies showed mild 
growth retardation and at 26 weeks* gestation she was 
admitted with premature labor and gave birth to a male 
infant weighing 550 gm, who died 30 minutes later.
Pregnancy in a woman requiring long-term dialysis is 
very uncommon, and when it occurs high residual renal 
function is usually maintained,1 Fetal loss because of 
prematurity is frequently the outcome,1 Our case illus­
trates a new cause of partial resistance to recombinant 
human erythropoietin action, only overcome after an 
important increase in dosage, An unexplained reduc­
tion in hemoglobin may be the lirst sign of pregnancy 
in women treated with recombinant human erythropoi­
etin in dialysis, Only one pregnancy has been previously 
reported in an anephric woman, who decided to termi­
nate it electivelv.a Therefore no cases of s
pregnancy in anephric women have been described. 
Very few cases of pregnancies in women on dialysis 
receiving recombinant human erythropoietin have been 
reported,1'” and to date there is no consensus for the 
use of recombinant human erythropoietin in this set­
ting. Although detrimental effects of recombinant hu­
man eiythropoietin in pregnancy cannot be suggested 
in our case, its use has not improved outcome of 
pregnancy1 and a note of caution must be underlined 
on its current use, because transfer of erythropoietin 
from mother to fetus has been demonstrated in mice. 1
Julio Pascual, MD , Fernando Liaiio, MD, and
Joaquin Or tuna, MD
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Effects of maternal inhalation of 40% oxygen on 
fetal oxygen saturation
To the Editors: In the paper by Dikiy et al. (Dilcly GA, 
Clark SL, Loucks CA. Intrapartum fetal pulse oximetry: 
the effects of maternal hyperoxia on fetal arterial oxy­
gen s aturatio n. Am J O h s t k t  ( i y n vx :o i .  1 9 9 4 ;  1 7 1 : 1 1 2  0 - 4 )  
the authors found a significant increase in fetal arterial 
oxygen saturation (Spoa) after giving 100% oxygen to 
the mother during labor but did not find a change in 
fetal oxygen saturation at a maternal inspired oxygen 
concentration (FiOo) of 40%. The authors therefore 
question the efficacy of maternal oxygen therapy in 
which inspired oxygen concentrations are primarily 
<40%,
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F ig . 1. Fetal S p o 2 increase after 20 minutes o f  40% (left) or 100% (right) oxygen administration to 
m oth er  p lotted  against initial fetal Spoa. Data were obtained from Table I o f  Dildy et aL
With the authors’ data concerning the short-term ad­
ministration of 40% and 100% oxygen, we plotted the 
fetal Spo2 increase against the initial fetal Spo2 (Fig. 1). 
The Spearman rank correlation coefficient (fs) is -  0.84 
at 40% and rs = —0.85 at 100% Fioa, which is statistically 
significant at both F i o 2 concentrations (ƒ; value 0.005 and
0.004, respectively). From the data points and a linear 
regression fit (see Fig. 1) it appears that when the initial 
fetal Spo2 is around 40%, then the Spo2 increase is 
> 15%, at both 40% and 100% Fio2. At a higher initial 
fetal Spo2 level (> 50%) no benefit is seen from 40% Fioa, 
but 100% Fic>2 still has some effect on Fetal Spo2. The 
regression line crosses the x axis at 58% for 40% Fioa and 
at 73% for 100% Imo2> so that there is a shift to the right 
with increasing maternal Fio2.
A similar analysis applied to the authors’ data on 
long-term (45 minutes) maternal oxygen inhalation of 
40% oxygen does not show a significant: correlation 
between initial value and increase of fetal Spoa. This 
can partly be explained by the somewhat higher mean 
initial fetal Spoa in the long-term administration group 
compared with the short-term administration group 
(58% vs 50%). Other clinical characteristics of the two 
groups studied, for instance, different fetal heart rate 
patterns, might he other reasons for this observation.
Two animal studies1, ~ on the assessment of the accu­
racy of fetal reflection pulse oximetry report a precision 
of 5.5% to (3.6% at low saturation values. It is encour­
aging that the results of the study of Dildy et al, in 
human fetuses show some fairly good correlations and 
that fetal reflectance pulse oximetry is apparently a tool 
suitable for human physiologic studies.
The data of Dildy et al. suggest to us that maternal 
oxygen administration with both high (100%) and mod­
erate (40%) oxygen concentrations is beneficial to those 
fetuses who are near a critical oxygen saturation range, 
Further studies using this new technique are warranted. 
For t h e a n a lysis o f the c flee t s o f m aternal hyperoxia o n 
fetal arterial oxygen saturation, the initial fetal Spoa 
should be taken into account.
Paul P. van den Berg, MI), and Henk W. Jongsma, PhD
Perinatal Research Group, Department o f  Obstetrics and Gynaecology,
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Reply
To the Editors: We appreciate the interest that was shown 
by van den Berg and jongsma in our recent, publication 
regarding the effects of maternal Fhk» on fetal Spoo 
measured by reflectance pulse oximetry.
In our original article, rcpcatcd-measures analysis of 
variance was used to evaluate the short-term effects
(group I, 20-minute duration, Fioy 21%, 40%, and 
100%) and long-term effects (group II, 45-minut;c du­
ration, FiOr> 21% and 40%) of supplemental maternal 
oxygen administration on fetal Spn2 in normal laboring 
women. According to van den Berg and Jongsma addi­
tional statistical analyses of the data reveal further 
observations and conclusions.
A matched t test was used to compare means of 
subgroups, with a two-tailed p < 0.05 considered sig­
nificant. Spearman regression-correlation analysis was 
used to determine relationships between the initial fetal 
Spoo before oxygen therapy and percent change in fetal 
Sp°a ([(Initial SpOy -  Final Spoo) -r Initial Spoy] x 
100] after therapy in treatment subgroups, with
